Acute angle-closure glaucoma complicating an intravitreal injection of bevacizumab

被引:14
作者
Semoun, O. [1 ]
Blumen-Ohana, E. [1 ]
de Preobrajensky, N. [1 ]
Nordmann, J. -P. [1 ]
机构
[1] CHNO XV XX, Serv Ophtalmol 2, F-75012 Paris, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2009年 / 32卷 / 01期
关键词
Intravitreal injection; Bevacizumab; Acute angle-closure glaucoma; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION;
D O I
10.1016/j.jfo.2008.11.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Introduction. - The use of anti-VEGF by intravitreal injection is being generalized, and the indications are multiplying. Ocular hypertension after injection can be a classic complication. Case report. - We report the case of an acute angle-closure glaucoma that occurred immediately after an intravitreal injection of 0.05 ml of bevacizumab. The patient was suffering from intravitreal hemorrhage complicating retinal central venous occlusion. The treatment consisted of intravenous acetazolamide and mannitol, associated with a local treatment. Discussion. - Elevation of intraocular pressure is frequent a short time after an intravitreal injection. However, this complication is more often moderate and transient, and does not usually require an adapted treatment. The physiopathology remains unclear. To our knowledge the occurrence of acute angle-closure glaucoma following an intravitreal injection is exceptional. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:58 / 59
页数:2
相关论文
共 8 条
  • [1] BAKRI SJ, 2007, EYE 0810
  • [2] Monitoring anti-VEGF drugs for treatment of exudative AMD
    Cohen, S. Y.
    Korobelnik, J.-F.
    Tadayoni, R.
    Coscas, G.
    Creuzot-Garcher, C.
    Devin, F.
    Gaudric, A.
    Mauget-Faysse, M.
    Sahel, J.-A.
    Souied, E.
    Weber, M.
    Soubrane, G.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (04): : 330 - 334
  • [3] Age-related macular degeneration and antivascular endothelial growth factor: a review
    Fajnkuchen, F.
    Cohen, S. -Y.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2008, 31 (01): : 94 - 110
  • [4] Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
    Ferrara, Napoleone
    Damico, Lisa
    Shams, Naveed
    Lowman, Henry
    Kim, Robert
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08): : 859 - 870
  • [5] Short-term intraocular pressure changes after intravitreal injection of bevacizumab
    Hollands, Hussein
    Wong, Jonathan
    Bruen, Robin
    Campbell, Robert J.
    Sharma, Sanjay
    Gale, Jeffery
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2007, 42 (06): : 807 - 811
  • [6] Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
    Iliev, Milko E.
    Domig, Diego
    Wolf-Schnurrbursch, Ute
    Wolf, Sebastian
    Sarra, Gian-Marco
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (06) : 1054 - 1056
  • [7] Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication
    Jalil, A.
    Fenerty, C.
    Charles, S.
    [J]. EYE, 2007, 21 (12) : 1541 - 1541
  • [8] Bevacizumab for neovascular ocular diseases
    Lynch, Shalini S.
    Cheng, Christine M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) : 614 - 625